Histologic features distinguish microsatellite-high from microsatellite-low and microsatellite-stable colorectal carcinomas, but do not differentiate germline mutations from methylation of the MLH1 promoter

被引:42
作者
Yearsley, Martha
Hampel, Heather
Lehman, Amy
Nakagawa, Hidewaki
de la Chapelle, Albert
Frankel, Wendy L. [1 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA
[2] Ohio State Univ, Div Human Canc Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Ctr Biostat, Columbus, OH 43210 USA
关键词
colorectal cancer; HNPCC; microsatellite instability; MSI high; MSI low; MLH1 promoter methylation;
D O I
10.1016/j.humpath.2006.02.009
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The detection of microsatellite-unstable (microsatellite instability [MSI]) colorectal carcinomas (CRCs) has prognostic value and can help screen for Lynch syndrome. We determined which histologic features are associated with MSI status and presence of germline mutation and/or methylation of MLH1 promoter. Patients diagnosed with CRC were offered participation in the Columbus-area hereditary nonpolyposis colorectal cancer syndrome study regardless of age or family history. Tumors were evaluated for MSI using a modified Bethesda panel of microsatellite markers. Methylation status of the MLH1 promoter was evaluated by rnethylation-specific polymerase chain reaction and bisulfite PCR followed by restriction digestion of tumor DNA. All patients with microsatellite-unstable tumors underwent mutation analysis of the MLH1, MSH2, and MSH6 genes by full sequencing of genomic DNA and by multiplex ligation probe assay of MLH1 and MSH2. Histologic end points were tumor type, grade, percentage of mucin, border, and lymphoid host response. Of the 482 CRCs. 87 were MSI with 69 MS1 high (MSI-H), 18 MSI low (MSI-L),. and 395 microsatellite stable (MISS). Of 87 MSI tumors, 12 had germline mutations and 34 had methylation of the MLH1 promoter. Younger age, but not histologic features, was significantly associated with a germline mutation. Percentage of mucin, histologic type, grade, and lymphoid host response differed significantly between MSI-H when compared with MSI-L or MSS. No difference was found between MSI-L versus MSS. Histologic features are associated with MSI-H CRC and are helpful to differentiate MSI-H from MSI-L and MSS. These features are not useful to distinguish MSI-L from MISS carcinomas, and those with a deleterious germline hereditary nonpolyposis colorectal cancer syndrome mutation from those with methylation of the MLH1 promoter region. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:831 / 838
页数:8
相关论文
共 40 条
  • [1] Histopathological identification of colon cancer with microsatellite instability
    Alexander, J
    Watanabe, T
    Wu, TT
    Rashid, A
    Li, SA
    Hamilton, SR
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (02) : 527 - 535
  • [2] Boland CR, 1998, CANCER RES, V58, P5248
  • [3] Deng GR, 1999, CANCER RES, V59, P2029
  • [4] GRAHAM DM, 1990, MODERN PATHOL, V3, P332
  • [5] Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer
    Gryfe, R
    Kim, H
    Hsieh, ETK
    Aronson, MD
    Holowaty, EJ
    Bull, SB
    Redston, M
    Gallinger, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (02) : 69 - 77
  • [6] Hamilton S.R., 2000, World Health Organization Classification of Tumours. Pathology and Genetics of Tumors of the Digestive System, P105
  • [7] Screening for the Lynch syndrome (Hereditary nonpolyposis colorectal cancer).
    Hampel, H
    Frankel, WL
    Martin, E
    Arnold, M
    Khanduja, K
    Kuebler, P
    Nakagawa, H
    Sotamaa, K
    Prior, TW
    Westman, J
    Panescu, J
    Fix, D
    Lockman, J
    Comeras, I
    de la Chapelle, A
    Ellison, C
    Melvin, S
    Winston, J
    Adeli, A
    Burak, W
    Chadwick, R
    Elkhatib, I
    Hemingway, T
    Jamieson, K
    Johnson, C
    LaJeunesse, J
    Liyanarachchi, S
    Rangel, P
    Soble, D
    Walker, M
    Wise, T
    Zhang, Y
    Schlanger, R
    Aguilar, P
    Hura, D
    Keith, J
    Kerner, B
    Lavalle, G
    Taylor, C
    Vara, T
    Zangmeister, J
    DeVictor, S
    Hines, L
    Lindsey, M
    Madhavan, J
    Padmanabhan, A
    Hamelberg, K
    Niemann, T
    Behrens, BC
    Blair, SC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (18) : 1851 - 1860
  • [8] Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
    Herman, JG
    Umar, A
    Polyak, K
    Graff, JR
    Ahuja, N
    Issa, JPJ
    Markowitz, S
    Willson, JKV
    Hamilton, SR
    Kinzler, KW
    Kane, MF
    Kolodner, RD
    Vogelstein, B
    Kunkel, TA
    Baylin, SB
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (12) : 6870 - 6875
  • [9] Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability
    Jass, JR
    Walsh, MD
    Barker, M
    Simms, LA
    Young, J
    Leggett, BA
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (07) : 858 - 866
  • [10] JASS JR, 1994, ANTICANCER RES, V14, P1631